IN8bio Inc.

NASDAQ: INAB · Real-Time Price · USD
2.35
-0.05 (-2.08%)
At close: Aug 15, 2025, 3:59 PM
2.29
-2.55%
After-hours: Aug 15, 2025, 06:39 PM EDT

IN8bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 2.53M n/a n/a n/a 3.75M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
498K 429K 1.26M 690K 631K 632K 627K 647K 637K n/a 351K 246K 274K 232K 89K 57K n/a 165K
Gross Profit
-498K -429K -702K -690K -631K -632K 3.12M -647K -637K n/a -351K -246K -274K -232K -89K -57K n/a -165K
Operating Income
-5.09M -5.55M -6.22M -7.09M -8.63M -8.56M -7.93M -7.17M -7.71M -7.53M -7.8M -7.4M -7.18M -6.14M -5.85M -3.39M -3.05M -2.36M
Interest Income
107K 110K 64K 23K 60K 83K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-5.09M -5.55M -6.16M -7.09M -8.63M -8.56M -7.6M -7.17M -7.71M -7.53M -7.8M -7.4M -7.18M -6.14M -5.85M -3.39M -3.05M -2.36M
Net Income
-5.09M -5.55M -6.16M -7.09M -8.63M -8.56M -7.6M -7.17M -7.71M -7.53M -7.8M -7.4M -7.18M -6.14M -5.85M -3.39M -3.05M -2.36M
Selling & General & Admin
2.71M 2.69M 2.63M 2.73M 3.53M 3.74M 2.45M 3.38M 3.58M 3.47M 3.88M 3.14M 3.67M 3.76M 3.16M 2.04M 986K 1.12M
Research & Development
2.49M 2.97M 3.59M 3.31M 5.16M 4.9M 4.52M 3.79M 4.13M 4.38M 3.92M 4.25M 3.5M 2.38M 2.69M 1.35M 2.06M 1.25M
Other Expenses
n/a -429K n/a 1.04M -60K -83K 957K n/a n/a -330K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
5.2M 5.23M 6.22M 7.09M 8.63M 8.56M 7.93M 7.17M 7.71M 7.53M 7.8M 7.4M 7.18M 6.14M 5.85M 3.39M 3.05M 2.36M
Interest Expense
n/a n/a n/a n/a n/a n/a 590K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a -627K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
5.2M 5.66M 7.49M 7.09M 8.63M 8.56M 7.93M 7.17M 7.71M 7.53M 7.8M 7.4M 7.18M 6.14M 5.85M 3.39M 3.05M 2.36M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
4.12B 83.48M 72.48M 47.32M 45.13M 43.29M 35.8M 31.55M 28.47M 24.73M 24.55M 21.66M 18.83M 18.8M 18.78M 18.75M 18.75M 19.35M
Shares Outstanding (Diluted)
4.12B 83.48M 72.48M 47.32M 45.13M 43.29M 35.8M 31.55M 28.47M 24.73M 24.55M 21.66M 18.83M 18.8M 18.78M 18.75M 18.75M 19.35M
EPS (Basic)
-1.24 -0.07 -0.09 -0.15 -0.19 -0.2 -0.21 -0.23 -0.27 -0.3 -0.32 -0.34 -0.38 -0.33 -0.31 -0.18 -0.16 -0.12
EPS (Diluted)
-1.24 -0.07 -0.09 -0.15 -0.19 -0.2 -0.21 -0.23 -0.27 -0.3 -0.32 -0.34 -0.38 -0.33 -0.31 -0.18 -0.16 -0.12
EBITDA
-5.09M -5.55M -5.46M -5.35M -8.06M -8.01M -7.3M -6.52M -7.08M -6.93M -7.45M -7.15M -6.91M -5.91M -5.76M -3.33M -2.86M -2.2M
EBIT
-5.09M -5.66M -6.22M -6.04M -8.69M -8.64M -7.93M -7.17M -7.71M -7.53M -7.8M -7.4M -7.18M -6.14M -5.85M -3.39M -3.05M -2.36M
Depreciation & Amortization
n/a 429K 702K 690K 631K 632K 627K 647K 637K 590K 351K 246K 274K 232K 89K 57K 190K 165K